Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ianthus Capital Holdings Inc C.IAN

Alternate Symbol(s):  ITHUF

Healthcare Cannabis
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.


CSE:IAN - Post by User

Ianthus Capital Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(30)
•••
Post by Bigchunguson Jun 10, 2019 11:22pm
75 Views
Post# 29814058

DionyMed Brands Inc. Announces First Quarter 2019 n kills it

DionyMed Brands Inc. Announces First Quarter 2019 n kills it14.2mm USD or 19mm CAD Q1 revenue. Approaching an annual run rate of 80mm CAD and a mere 100mm cap. This e-commerce platform distributes to over 900 retailers and makes thousands of direct to consumer deliveries daily and is expanding rapidly. This puts DYME in approx 13th on the U.S. overall cannabis revenue generator and exceeds many established Canadian producers sales, including Aphria and other noteworthy LPs. Who wouldn’t want cannabis delivered straight to your door? This company is largely under the radar and worth noting, a near 52w low. Super low float, so this could easily hit the analysts target of $6.00 from its current $2.08 in short order. Anticipated 2019 revenue of 162 million CAD

Order here:  https://www.orderchill.com/

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities